Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: Versant Ventures

JLABS @ Toronto

Thursday, February 15, 2018 from 10:30 AM to 1:00 PM (EST)

Investor Spotlight: Versant Ventures

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info Feb 14, 2018 CA$15.00 CA$1.90
Media/Press   more info Feb 7, 2018 Free CA$0.00
Volunteer   more info Feb 7, 2018 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: Versant Ventures

Event Details

Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.

On February 15th, Stefan Larson, Venture Partner at Versant Ventures will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online. Committed to transforming the healthcare landscape through innovation, Versant Ventures is eager to help you make an impact in healthcare.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due January 25th, 2018. Apply Here.

Program Overview:
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs who are building the next generation of great healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, nearly 70 Versant companies have achieved successful acquisitions or IPOs.

Following the presentation, don't miss this opportunity to introduce yourself to Stefan during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Versant Ventures will provide an intimate forum to discuss your company.

Agenda:
10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on January 25th, 2018.

Fees:
$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on February 14th (or sold out).

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Versant Ventures Representative:
Stefan Larson | Venture Partner, Versant Ventures
Stefan Larson is a Venture Partner and serves on the board of Northern Biologics, a Versant portfolio company. Based in the MaRS Discovery District, Stefan was the founding CEO of Blueline Bioscience, a Versant Discovery Engine, and was the founding CEO of Northern Biologics.

Stefan joined Versant after spending three years as the co-founder and CEO of Tornado Medical Systems, a revenue stage medical imaging and spectroscopy company. He previously held the position of Associate Principal with McKinsey & Company, serving global clients in healthcare and technology. He is currently a director of the MaRS Discovery District and Ontario Bioscience Innovation Organization (OBIO), and is a recipient of the Arbor Award for Exceptional Volunteer Service to the University of Toronto.

Stefan received his B.Sc. in Biology from McGill University, and his M.Sc. in Molecular and Medical Genetics from the University of Toronto. He completed his Ph.D. in Biophysics at Stanford University, where he helped build and launch Folding@home, the world’s most successful scientific public distributed computing platform.
Connect with Stefan:   Connect on LinkedIn

Have questions about Investor Spotlight: Versant Ventures? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where


JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1
Canada

Thursday, February 15, 2018 from 10:30 AM to 1:00 PM (EST)


  Add to my calendar

Organizer

JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
Investor Spotlight: Versant Ventures
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.